Variant | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AF EXOME | AF GENOME | Disease | Disease Class | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
1.000 | 0.080 | 5 | 132656189 | intron variant | C/T | snv | 0.15 |
|
Respiratory Tract Diseases; Immune System Diseases | 0.700 | 1.000 | 1 | 2019 | 2019 | |||||||
|
1.000 | 0.080 | 5 | 132656189 | intron variant | C/T | snv | 0.15 |
|
Respiratory Tract Diseases | 0.700 | 1.000 | 1 | 2019 | 2019 | |||||||
|
0.790 | 0.160 | 5 | 132660753 | 3 prime UTR variant | A/G | snv | 0.81 |
|
Skin and Connective Tissue Diseases | 0.700 | 1.000 | 1 | 2019 | 2019 | |||||||
|
0.790 | 0.160 | 5 | 132660753 | 3 prime UTR variant | A/G | snv | 0.81 |
|
Respiratory Tract Diseases; Immune System Diseases | 0.700 | 1.000 | 1 | 2018 | 2018 | |||||||
|
0.807 | 0.240 | 5 | 132660808 | 3 prime UTR variant | A/C | snv | 0.67 |
|
Immune System Diseases | 0.700 | 1.000 | 1 | 2017 | 2017 | |||||||
|
0.882 | 0.160 | 5 | 132660151 | intron variant | T/A;C | snv | 0.68 |
|
Immune System Diseases | 0.700 | 1.000 | 1 | 2016 | 2016 | |||||||
|
1.000 | 0.120 | 5 | 132655393 | intron variant | T/C;G | snv |
|
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Skin and Connective Tissue Diseases; Immune System Diseases | 0.700 | 1.000 | 1 | 2015 | 2015 | ||||||||
|
0.790 | 0.160 | 5 | 132660753 | 3 prime UTR variant | A/G | snv | 0.81 |
|
Skin and Connective Tissue Diseases | 0.700 | 1.000 | 1 | 2015 | 2015 | |||||||
|
0.807 | 0.240 | 5 | 132660808 | 3 prime UTR variant | A/C | snv | 0.67 |
|
Skin and Connective Tissue Diseases | 0.700 | 1.000 | 1 | 2015 | 2015 | |||||||
|
0.882 | 0.160 | 5 | 132660151 | intron variant | T/A;C | snv | 0.68 |
|
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Skin and Connective Tissue Diseases; Immune System Diseases | 0.800 | 1.000 | 2 | 2013 | 2015 | |||||||
|
0.585 | 0.720 | 5 | 132660272 | missense variant | A/G | snv | 0.72 | 0.77 |
|
Immune System Diseases | 0.800 | 1.000 | 1 | 2013 | 2013 | ||||||
|
0.790 | 0.160 | 5 | 132660753 | 3 prime UTR variant | A/G | snv | 0.81 |
|
Skin and Connective Tissue Diseases | 0.800 | 1.000 | 1 | 2012 | 2012 | |||||||
|
0.585 | 0.720 | 5 | 132660272 | missense variant | A/G | snv | 0.72 | 0.77 |
|
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases | 0.810 | 1.000 | 1 | 2012 | 2014 | ||||||
|
0.882 | 0.160 | 5 | 132660151 | intron variant | T/A;C | snv | 0.68 |
|
Respiratory Tract Diseases; Immune System Diseases | 0.840 | 1.000 | 1 | 2010 | 2018 | |||||||
|
0.585 | 0.720 | 5 | 132660272 | missense variant | A/G | snv | 0.72 | 0.77 |
|
Respiratory Tract Diseases; Immune System Diseases | 0.800 | 1.000 | 1 | 2009 | 2018 | ||||||
|
0.585 | 0.720 | 5 | 132660272 | missense variant | A/G | snv | 0.72 | 0.77 |
|
Skin and Connective Tissue Diseases | 0.860 | 0.900 | 3 | 2008 | 2015 |